Tag: ELISA kit

Know Everything About Anti-Myeloperoxidase Antibody

Myeloperoxidase, the most well-known p-ANCA antibody, is most widely recognized. It is a 140kDa cationic molecule found primarily in the azurophilic granules from neutrophils, monocytes, and monocytes. This enzyme, which can account for as much as 5% of total cell proteins, generates anti-microbial chlorinated oxide species from hydrogen peroxide generated by the neutrophil respiratory burst.

Autoantibodies are able to recognize conformational determinants, but they do not block enzyme activity. Only 10-35% of P -ANCAs were found to have anti-myeloperoxidase activity in different studies. Anti-Myeloperoxidase is an enzyme found in neutrophil primary granules as well as monocyte lysosomes. You can know more about anti-myeloperoxidase antibodies via https://www.bosterbio.com/anti-myeloperoxidase-antibody-a00372-boster.html.

MPO is responsible for the conversion of hydrogen peroxide into hypochlorite or hypochlorous acid. MPO is encoded in a single gene. This gene undergoes translational modifications to make the active enzyme found within leukocytes. MPO autoantibodies can be found in many diseases and could play a role in the pathogenesis vascular inflammation in patients suffering from microscopic polyangiitis.

MPO ANCA may not be specific to MPA and can also be found in patients with systemic lupus erythematosus, Goodpasture syndrome, Churg-Strauss Syndrome, or lupus nephritis. Wegener granulomatosis, Lupus nephritis, Goodpasture syndrome and Lupus nephritis may also present with progressive renal failure and azotemia.

Systemic vasculitides such as Wegener’s Granulomatosis, Microscopic Polyangiitis, and Churg Strauss Syndrome are often associated with anti-neutrophil cell cytoplasmic antibodies found in active necrotizing or crescentic glomerulonephritis. This study shows that ANCA is more common in MPA cases than it is in Proteinase3 and Myeloperoxidase cases.

Know About NME1 Antibody

NME1 can also be called NDPKA (Nucleoside phosphate kinase A), NM23 (Metastasis inhibitor factor nm23), and GAAD(Granzyme A activated DNase). It is part of the NDK family. NME1 was discovered because it has a reduced mRNA transcript level in highly metastatic cells. 

Nucleoside diphosphate kinase is a hexamer that is composed of 'A (encoded in this gene) as well as 'B (encoded via NME2) isoforms. In aggressive neuroblastomas, mutations in this gene were identified. This gene has been affected by two transcript variants that encode different isoforms. You can buy high –quality NME1 antigen equipment via the internet.

This gene has been co-transcribed with the neighboring gene NME2. They encode a fusion protein that shares sequence identity with each gene product. NME/NM23 nucleoside diphosphate kinase kinase1 (NME1), an endoplasmic reticulum-associated SET-complex component that contains pp32 (GzmA), and pp32 substrates. 

This gene encodes this protein and is found on chromosome 17q22. NME/NM23 nucleoside phosphate kinase 1- (NME1) plays a major role in tumor metastasis suppression. It binds and nicks the nuclease-hypersensitive element (NHE) of the c-myc promoter, recognizes the S1 nuclease-hypersensitive region (5'-SHS silencer) and the NHE basal promoter of platelet-derived growth factor.

It activates to nick DNA and translocates from the endoplasmic reticulum to the nucleus. This initiates single-stranded damage. The NDK/NME/NM23 protein kinase (encoded in the gene) family consists of at least eight distinct proteins with different cellular localization. This group is capable of inhibiting metastasis in many types of tumor cells.